Celyad - News

Corporate › Non-regulated April 01, 2019

Celyad Announces April 2019 Investor Conference Schedule

Corporate › Non-regulated March 22, 2019

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call

Corporate › Non-regulated March 11, 2019

Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City

Corporate › Non-regulated March 04, 2019

Celyad Appoints Anne Moore as Vice President Corporate Strategy

Corporate › Non-regulated February 21, 2019

Celyad Announces February and March 2019 Investor Conference Schedule

Corporate › Non-regulated January 07, 2019

Celyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDS

Corporate › Non-regulated November 15, 2018

Celyad to Participate at Upcoming Healthcare Conferences

Corporate › Non-regulated October 04, 2018

Celyad to present CYAD-01 solid tumor clinical updates and pre-clinical pipeline data at the 2018 SITC Annual Meeting

Corporate › Non-regulated September 26, 2018

Celyad appoints Carri Duncan as Vice-President Corporate Development & Communications

Corporate › Non-regulated September 25, 2018

Celyad to Participate at Upcoming Healthcare Conferences

Corporate › Non-regulated September 05, 2018

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Preconditioning Chemotherapy

Corporate › Non-regulated August 30, 2018

Celyad to participate at upcoming healthcare conferences in September